Navigation Links
Oncologists Rank Aloxi's Marketing Message Most Influential in the Chemotherapy-Induced Nausea and Vomiting Drug Market
Date:12/4/2008

WALTHAM, Mass., Dec. 4 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Eisai/Helsinn Healthcare's Aloxi's marketing message ("Better in acute, better in delayed") is rated the most influential by oncologists in the chemotherapy-induced nausea and vomiting drug market. Oncologists accurately identified Aloxi's messages with the brand, highlighting the strength of the Aloxi messaging campaign.

According to the new report entitled Brands & Strategies: Chemotherapy-Induced Nausea and Vomiting, U.S. physicians rate Aloxi higher than Merck's Emend in terms of top-of-mind therapy despite Aloxi and Emend launching in the same year in the United States. Emend scored low in terms of brand recognition with less than 20 percent of oncologists identifying the correct messages associated with the brand. Surveyed oncologists rate Emend's marketing messages ("More complete prevention comes from two directions" and "Used in more than 2.7 million chemotherapy cycles over 5 years") in the bottom three most influential messages, with the latter being the least identifiable message. Despite this, both Emend and Aloxi are forecasted to dominate the chemotherapy-induced nausea and vomiting market in 2012.

"Promotional spending on chemotherapy-induced nausea and vomiting drug therapies in the United States is relatively low compared to other therapeutic areas," said Marcus Hoyle, analyst at Decision Resources. "In 2007 $61 million was spent by the leading competitors (Merck, MGI Pharma/Eisai, Roche and Sanofi-Aventis) in the United States to promote their respective brands."

About Brands & Strategies

The Brands & Strategies report series from Decision Resources reveals what it takes to be successful in a pharmaceutical market. It offers the most comprehensive commercial analysis of the brands and
'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. MedTrust Online Collaborates With Oracle and Dell to Provide Oncologists With the Next Generation Tool for Personalized Care Delivery
2. Society of Gynecologic Oncologists 39th Annual Meeting on Womens Cancer to Include Sessions on HPV and Cervical Cancer
3. South Florida Gynecologic Oncologists Begin Using LUMA(R) Cervical Pre-Cancer Imaging Device
4. Despite Oncologists Willingness to Prescribe Avastin for Treatment of Breast Cancer, the FDA is Likely to Rule Against the Product on February 23
5. Society of Gynecologic Oncologists to Host 39th Annual Meeting on Womens Cancer
6. 91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs
7. Expert Neurosurgeons and Neuro-oncologists to Speak at 6th Annual Brain Tumor Awareness Day Convention
8. Jefferson oncologists show focused radiation is effective as surgery against nerve tumor
9. Leading Oncologists from Across the Country Hold Emergency Meeting on New Government Reimbursement Policy for Medicare Patients with Cancer
10. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
11. Jefferson radiation oncologists use real-time system to plant seeds against cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Ever thought you could quit smoking while you,re ...roundbreaking new system for quitting is easy, pai...enty eight days your cravings and desire to smoke ... (PRWEB) December 1, 2009 -- Izabella had tried...iction to nicotine, smoking at least a pack a day....
(Date:12/1/2009)... ,, NEW YORK, Dec. 1 Ovid, part...he development and delivery of customizable electr...fic and academic markets, will be showcasing recen...-to-market cross-platform search solution, and the... on the American Psychological Association,s (APA,...
(Date:12/1/2009)...afety Authority Encourages Older Persons and Healt...umer Tips Based Upon Authority Data ,, HARRIS...y percent of all vaccine preventable deaths occur ...ing homes, according to highlighted studies in the...mber Patient Safety Advisory . ,, According to...
(Date:12/1/2009)...hat happiness declines with age are more likely to...inking. Their misguided negative view of the aging...ibly, and encourage them to make the most of the p...ese findings 1 by Dr. John Garry and Dr. Maria Lo...and, are published online in Springer,s Journal o...
(Date:12/1/2009)...ystem tied to academic achievement, study finds ,...trong cardiovascular system in young adulthood may... and more overall success later in life, new resea...people know (or should know) the benefits of exerc...of a new study, appearing in this week,s online is...
Breaking Medicine News(10 mins):Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 2Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 3Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 4Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 5Health News:Binge drinking youths find getting old a drag 2Health News:Exercise May Lead to a Smarter, More Successful You 2Health News:Exercise May Lead to a Smarter, More Successful You 3
...surgery and radiation yields better mobility, lowe...rd compression. // Metastatic epidural spinal...mmon complication of cancer, occurring in 5 to 14 ...le to walk. Surgery, in the form of the simple lam...
...regnancies have recently also been under intense s...t sexually transmitted diseases (e.g. Gonorrhea an...ondoms undoubtedly provide protection even the mos...that how much protection do they provide and how f...
...ing the genetic pathway involved in the developmen...sory hair cells in the ear –– the cells largely re... that enable the perception of sound. Situated...al signals, which they then direct to the brain. ...
...20 lives in the past two weeks in the west Nepal d...t in the neighboring Indian state of UP // . ...d 10 deaths each in the townships of Tikapur and D...istrict. The final death toll due to the dise...
...ausing more deaths especially in children. 11 more...sed by the rapidly spreading killer virus // in t...e was so far confined largely to Gorakhpur and nei...nasi, Sitapur and Rae Bareli located far away. ...
...ction of chicken doctors because of chicken pox va...pitalizations and visits to pox // . The latest is... Varicella vaccine is recommended for routine imm...the article. Before its licensure in 1995, almost ...
Other Medicine News:Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 2Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 3Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 4Health News:Encephalitis Claims 131 lives in Uttar Pradesh 2Health News:Chicken Pox Hospitalizations Are Becoming Less 2
(Date:12/1/2009)..., ALBUQUERQUE, N.M., Dec. 1 Exag...ratory that discovers, develops and markets propri...nt of Scott Glenn as chairman of the company,s boa... Prior to joining Exagen, Glenn was managing partn...number of successful biomedical companies includin...
(Date:12/1/2009)... , BEIJING, Dec. 1 /PRNewswire-Asia/ -...rovider of biopharmaceutical products in China, an...hase order for its H1N1 vaccine, PANFLU.1(TM),fro...hnology for the national,purchase plan. Under this...,additional one million doses of PANFLU.1 (TM) (15...
(Date:12/1/2009)... , REDWOOD CITY, Calif., Dec. 1 /PRNewswire/ ...ts relationship and the signing of its second agre...s Ltd., the world,s largest generic drug manufactu...harmaceutical products. Codexis announced an earl...the new agreement, Teva will use Codexis biocataly...
Breaking Medicine Technology:Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Codexis Expands Collaboration with Teva 2Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems Inc 51916 1Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems Inc 51916 2Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz 51911 1Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz 51911 2Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz 51911 3National Jewish Health Named Top Respiratory Hospital for 12th Consecutive Year 51906 1National Jewish Health Named Top Respiratory Hospital for 12th Consecutive Year 51906 2
...s published in the journal Blood found 92 percent ...hromboses, CHESHIRE, Conn., Aug. 20 Patients wit...2 percent reduction in the,incidence of life-threa...t,with Soliris(TM) (eculizumab), according to an a...ine in Blood, the journal of the American Society ...
...H MEETING, Pa., Aug. 1 Genaera,Corporation (Nasda...,MedImmune, Inc. has initiated a multi-dose, Phase...Ab) targeting interleukin-9 (IL-9) in adults with,...ose-escalation study is,designed to evaluate the s...tibody. This trial is the second Phase 2a study cu...
Other Medicine Technology:PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 2PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 3PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 5PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 6PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 7PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 8Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 2Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 3Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 4
BTC/1Q - Cast Aluminum Base - Model 1Q70-R
BTC/1Q - Cast Aluminum Base - Model 1Q70
BTT/1P - Tubular Base - Model 1P63
BTT/1P - Tubular Base - Model 1P62
Medicine Products: